TB-500 is related to thymosin beta-4, a naturally occurring peptide involved in cell migration, tissue repair, and wound-healing pathways.
Animal and laboratory research involving thymosin beta-4 and related compounds provides the biological rationale for interest in TB-500.
Human clinical research has focused primarily on full-length thymosin beta-4 rather than TB-500.
No human clinical trial has established TB-500 as an effective treatment for tendon, muscle, joint, or connective-tissue injury.
For that reason, treatment duration and dosing come from clinical protocols rather than established human therapeutic guidelines.